Last reviewed · How we verify
NCT06969755: BEEST
Biomarkers to Enhance Early Schizophrenia Treatment
Phase 4 trial testing aripiprazole in Schizophenia Disorder in 180 participants. Not yet recruiting.
30 July 2030
Quick facts
| Lead sponsor | Northwell Health |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 30 July 2025 |
| Primary completion | 30 July 2030 |
| Estimated completion | 30 July 2030 |
| Sites | 1 location across United States |
Drugs / interventions tested
- aripiprazole (aripiprazole) — full drug profile →
- risperidone (risperidone) — full drug profile →
- clozapine (CLOZAPINE) — full drug profile →
Conditions studied
- Schizophenia Disorder — all drugs for Schizophenia Disorder →
Sponsor
Northwell Health — full company profile →
Who can join
Adults 18 to 35, any sex, with Schizophenia Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06969755
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of aripiprazole
Trials testing the same drug.
- NCT03557931 — A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schiz · Phase 2 · completed
- NCT03148509 — A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway · Phase 4 · unknown
Other recruiting trials for Schizophenia Disorder
Currently open trials in the same condition.
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
- NCT06865937 — Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33) · NA · recruiting
- NCT06856161 — A Novel Blood Test as a Biomarker in Mental Health · recruiting
- NCT06831435 — Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study · NA · recruiting
- NCT07453420 — Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-p · active not recruiting
Other Northwell Health trials
Trials by the same sponsor.
- NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
- NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
- NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
- NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
- NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06969755 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwell Health
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06969755.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing